{{Rsnum
|rsid=2266637
|Gene=GSTT1
|Chromosome=22
|position=24376845
|Orientation=minus
|GMAF=0.04683
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{PharmGKB
|RSID=rs2266637
|Name_s=GSTT1:Val169Ile
|Gene_s=GSTT1
|Feature=Exon/NonSyn
|Evidence=PubMed ID:18056202
|Annotation=This variant was present at a frequency of 0.126 in African American DNA samples from the Coriell Repository (HD100AA) and when expressed in COS-1 cells had the same level of immunoreactive protein as wild type.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA162361060
}}

{{GET Evidence
|gene=GSTT1
|aa_change=Val169Ile
|aa_change_short=V169I
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2266637
|overall_frequency_n=496
|overall_frequency_d=8800
|overall_frequency=0.0563636
|n_genomes=4
|n_genomes_annotated=0
|n_haplomes=7
|n_articles=1
|n_articles_annotated=1
|in_pharmgkb=Y
|pph2_score=0.023
|nblosum100=-4
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=22643671
|Title=PharmGKB summary: very important pharmacogene information for GSTT1.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}